Inari Medical logo

Inari MedicalNASDAQ: NARI

Profile

Sector:

Healthcare

Country:

United States

IPO:

22 May 2020

Next earnings report:

01 November 2024

Last dividends:

N/A

Next dividends:

N/A
$2.83 B
-43%vs. 3y high
85%vs. sector
-vs. 3y high
-vs. sector
-82%vs. 3y high
86%vs. sector
-74%vs. 3y high
60%vs. sector

Price

after hours | Thu, 31 Oct 2024 20:56:39 GMT
$48.40+$1.30(+2.76%)

Dividend

No data over the past 3 years
$153.39 M$160.57 M
$153.39 M-$18.37 M

Analysts recommendations

Institutional Ownership

NARI Latest News

PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism
globenewswire.com29 October 2024 Sentiment: POSITIVE

Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization Primary endpoint win driven by both hard clinical outcomes and hospital resource utilization

Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y
zacks.com29 October 2024 Sentiment: NEUTRAL

NARI's third-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the company continues to incur operating losses.

Inari Medical, Inc. (NARI) Q3 2024 Earnings Call Transcript
seekingalpha.com28 October 2024 Sentiment: POSITIVE

Inari Medical, Inc. (NASDAQ:NARI ) Q3 2024 Earnings Conference Call October 28, 2024 4:30 PM ET Company Participants Marissa Bych - VP, IR Drew Hykes - President and CEO Kevin Strange - CFO Tom Tu - Chief Medical Officer Conference Call Participants Kallum Titchmarsh - Morgan Stanley Marie Thibault - BTIG David Rescott - Baird Chris Pasquale - Nephron Research Stephanie Piazzola - Bank of America Lei Huang - Wells Fargo Zachary Day - Canaccord Genuity Michael Sarcone - Jefferies Ravi Misra - Truist Securities Matthew Blackman - Stifel Operator Good day, and welcome to the Inari Medical Third Quarter 2024 Earnings Call. [Operator Instructions] Also, please be aware that today's call is being recorded.

Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates
zacks.com28 October 2024 Sentiment: NEUTRAL

Inari Medical, Inc. (NARI) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to earnings of $0.05 per share a year ago.

Inari Medical Reports Third Quarter 2024 Financial Results
globenewswire.com28 October 2024 Sentiment: POSITIVE

IRVINE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its third quarter ended September 30, 2024.

Okami Medical Announces Closing Of $32.5M Financing
prnewswire.com21 October 2024 Sentiment: POSITIVE

ALISO VIEJO, Calif. , Oct. 21, 2024 /PRNewswire/ -- Okami Medical today announced the closing of a $32.5M financing led by new investor Vensana Capital and joined by existing investors including U.S. Venture Partners, members of Okami's board of directors, and other medical device industry veterans.

Analysts Estimate Inari Medical, Inc. (NARI) to Report a Decline in Earnings: What to Look Out for
zacks.com21 October 2024 Sentiment: NEGATIVE

Inari Medical (NARI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Inari Medical to Host Analyst and Investor Meeting Following PEERLESS RCT Presentation
globenewswire.com07 October 2024 Sentiment: POSITIVE

IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will host an analyst and investor meeting to discuss the PEERLESS study following its presentation at the Late-Breaking Clinical Trial Sessions at the 2024 Transcatheter Cardiovascular Therapeutics (TCT) Annual Scientific Symposium in Washington, D.C. The analyst and investor meeting will be held on Tuesday, October 29, 2024 at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time.

Inari Medical to Announce Third Quarter 2024 Financial Results
globenewswire.com07 October 2024 Sentiment: POSITIVE

IRVINE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its third quarter 2024 financial results on Monday, October 28, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Inari Medical Inc (NARI) Shares Up 3.22% on Oct 2
gurufocus.com02 October 2024 Sentiment: POSITIVE

Shares of Inari Medical Inc (NARI, Financial) surged 3.22% in mid-day trading on Oct 2. The stock reached an intraday high of $42.21, before settling at $41.94, up from its previous close of $40.63.

What type of business is Inari Medical?

Inari Medical is a company that manufactures specialized medical equipment for minimally invasive treatment of patients suffering from venous diseases. It was founded in 2011 and is headquartered in Irvine, California. The company began its direct commercial activities in 2017 after the approval by the US Food and Drug Administration (FDA) of its first two devices: - ClotTriever for the treatment of deep vein thrombosis. - FlowTriever for the treatment of pulmonary embolism and clots in the right atrium.

What sector is Inari Medical in?

Inari Medical is in the Healthcare sector

What industry is Inari Medical in?

Inari Medical is in the Medical Devices industry

What country is Inari Medical from?

Inari Medical is headquartered in United States

When did Inari Medical go public?

Inari Medical initial public offering (IPO) was on 22 May 2020

What is Inari Medical website?

https://www.inarimedical.com

Is Inari Medical in the S&P 500?

No, Inari Medical is not included in the S&P 500 index

Is Inari Medical in the NASDAQ 100?

No, Inari Medical is not included in the NASDAQ 100 index

Is Inari Medical in the Dow Jones?

No, Inari Medical is not included in the Dow Jones index

When was Inari Medical the previous earnings report?

No data

When does Inari Medical earnings report?

The next expected earnings date for Inari Medical is 01 November 2024